No Data
No Data
Express News | Summary of shareholding reductions of listed companies on December 15.
Express News | Aopu Mai: Shareholder Huajie Investment, holding over 5% of shares, plans to reduce their Shareholding by no more than 3% of the company's shares.
Express News | Ping An Securities Pharmaceutical Industry 2025 Annual Strategy Report: Exploring new growth from payment sources, focusing on innovation, going overseas, equipment upgrades, and Consumer recovery.
Aupro Bio(688293.SH): Shareholders PICC Life and Chengda collectively reduced their shareholdings in the company by 1.00%.
On November 15, Gelonghui reported that Aopu Mai (688293.SH) announced that on November 15, 2024, it received a notification letter from its shareholder, Guoshou Chengda, which holds more than 5% of the shares, regarding the reduction of shareholding by 1%. From November 7 to November 15, 2024, Guoshou Chengda reduced its shares in the company by a total of 1,147,724 shares through centralized bidding trades (hereinafter referred to as "this equity change"), representing 1.00% of the company's total share capital of 114,772,460 shares. After this equity change, Guoshou.
Aupuma (688293): The income from the culture medium continues to increase rapidly.
Item: The company released the third quarter report for 2024. In the first three quarters of 2024, the company achieved revenue of 0.216 billion yuan, a year-on-year increase of 25.73%, and a net income attributable to the mother of 0.027 billion yuan, a year-on-year decline of 36.93%, net of non-recurring items.
Aupuma (688293): High growth in Q3 culture medium, short-term profit affected by tax rate changes, overseas market growth impressive.
OuPumai released its 2024 third-quarter report. In 2024 Q1-Q3, revenue reached 0.216 billion yuan, a year-on-year growth of 25.73%; net income attributable to equity holders was 27.24 million yuan, a year-on-year decline of 36.93%; after deducting non-recurring items, the
No Data